 |
Page History
...
Data Element | Description and Corresponding CTRP PA Data Element Where Applicable | ||||||
Biomarker Name | Name of the biomarker as indicated in the Protocol document. | ||||||
Biomarker Use | Value that describes the biomarker use. Valid values include:
| ||||||
Biomarker Purpose | Value that describes the reason or intention of the biomarker in the clinical study. Valid values include:
| ||||||
NCI ID |
| ||||||
ClinicalTrials.gov NCT ID |
| ||||||
Lead Org ID |
| ||||||
Phase |
| ||||||
| Disease Site | Anatomic site terms that identify the anatomic cancer site(s) on which a trial or study is focused. For a list of values, refer to Anatomic Sites. When a trial has multiple disease sites, the report uses a semicolon (;) to separate values. | ||||||
Official Title |
| ||||||
Current Trial Overall Status |
| ||||||
Processing Status |
| ||||||
| Intervention Name | Standard name used to refer to an intervention. For drugs, this is the generic name. For investigational new drugs that do not yet have a generic name, this may be the chemical name, company code, or serial number. When a trial has multiple intervention names, the report uses a semicolon (;) to separate values. | ||||||
| Intervention Type | Mode of intervention, for example, drug or device. When a trial has multiple intervention types, the report uses a semicolon (;) to separate values. |
